U.S. flag

An official website of the United States government

NM_012275.3(IL36RN):c.244-5G>A AND Generalized pustular psoriasis

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
May 30, 2022
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001037461.8

Allele description [Variation Report for NM_012275.3(IL36RN):c.244-5G>A]

NM_012275.3(IL36RN):c.244-5G>A

Gene:
IL36RN:interleukin 36 receptor antagonist [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2q14.1
Genomic location:
Preferred name:
NM_012275.3(IL36RN):c.244-5G>A
HGVS:
  • NC_000002.12:g.113062448G>A
  • NG_031864.1:g.8811G>A
  • NM_012275.3:c.244-5G>AMANE SELECT
  • NM_173170.1:c.244-5G>A
  • LRG_730t1:c.244-5G>A
  • LRG_730t2:c.244-5G>A
  • LRG_730:g.8811G>A
  • NC_000002.11:g.113820025G>A
  • NM_012275.2:c.244-5G>A
Links:
dbSNP: rs754661425
NCBI 1000 Genomes Browser:
rs754661425
Molecular consequence:
  • NM_012275.3:c.244-5G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_173170.1:c.244-5G>A - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Name:
Generalized pustular psoriasis
Identifiers:
MONDO: MONDO:0100491; MedGen: C0343055

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001200875Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(May 30, 2022)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV001288880Illumina Laboratory Services, Illumina
criteria provided, single submitter

(ICSL Variant Classification Criteria 13 December 2019)
Uncertain significance
(Jan 13, 2018)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Invitae, SCV001200875.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This sequence change falls in intron 4 of the IL36RN gene. It does not directly change the encoded amino acid sequence of the IL36RN protein. This variant is present in population databases (rs754661425, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with IL36RN-related conditions. ClinVar contains an entry for this variant (Variation ID: 836349). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Illumina Laboratory Services, Illumina, SCV001288880.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Dec 24, 2023